The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 1st 2025
In clinical trials, the dihydroergotamine (DHE) nasal powder had favorable safety profiles and rapid pain relief in patients with migraine with or without aura.
Study: Milk Allergy Guidelines May Cause Overdiagnosis in Babies, Children
April 17th 2020Researchers have found that approximately 1% of children have an allergy to cow’s milk, but up to 14% of families believe their children may have the condition, pointing to official guidelines for detecting cow’s milk allergy as a possible cause for the overdiagnosis.
Read More
Survey Shows Adopting New Vancomycin Guidelines is Priority for Pharmacists Despite Pandemic
April 16th 2020A survey conducted between March 30 to April 6 by InsightRx found that implementing the new vancomycin guidelines into the pharmacy community is as important as the coronavirus disease 2019 (COVID-19) in the healthcare system.
Read More
Patients With Lupus Experiencing Difficulties Accessing Hydroxychloroquine, Chloroquine
April 15th 2020Patients with lupus are experiencing difficulties in accessing medications hydroxychloroquine and chloroquine, 2 medications currently being investigated as potential treatment for the coronavirus 2019 disease.
Read More
Relief Fund to Support Pharmacy Professionals Impacted by COVID-19
April 15th 2020Parata Systems has launched the Pharmacy Employee Relief Fund with an initial commitment of $100,000 to support employees of retail, long-term care, hospital, and direct-to-home pharmacies across the United States affected by the coronavirus disease 2019.
Read More
Research Shows Vitamin D Supplements Do Not Prevent Osteoporotic Fractures
April 15th 2020Although vitamin D helps the body absorb minerals essential for bone health, previous studies have found conflicting evidence on whether low vitamin D levels actually increase the risk of osteoporotic fractures and whether vitamin D supplements can reduce the risk.
Read More
Study Examining Higher Chloroquine Doses in COVID-19 Halted Early Due to Safety Concerns
April 14th 2020A study based in Brazil has been halted early for safety reasons after patients with coronavirus disease 2019 taking a higher dose of chloroquine developed irregular heart rates that increased their risk of a potentially fatal heart arrhythmia.
Read More
Limited Global Supply, Ethical Concerns Could Curb Use of Antimalarials Against COVID-19
April 13th 2020Although chloroquine and hydroxychloroquine have been touted as potential treatments for COVID-19, physicians in Italy have warned that the global supply may not be able to keep up with demand.
Read More